---

Top Highlights for October 2012: (Please click on news title to view details)

 

1. Australia's Phosphagenics licences injectable technology to Stides Acrolab, India
2. India's Advinus enters into Joint Drug Discovery deal with Takeda, Japan 
3. Dr.Reddy's Lab,India to acquire Netherlands's pharma company- OctoPlus NV for 27.4 million euros
4. Mylan Inc acquires India's SMS pharmaceuticals units for $33 millions
5. Sanofi investing $300 million in India's Shantha Biotechnics facility for Insulin production
6. Piramal Enterprise, India eyeing acquisitions in US & Europe to expand CRAMS business
7. India eyes $40 billion global generic market; patents held by MNCs to expire in over 3 years
8. India's Lupin eyes 15 new drug launches in US by March 2013
9. India's biotech to be $125 billion giant by 2025